CENCORA INC (ABG.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:ABG • US03073E1055

284 EUR
-0.85 (-0.3%)
Last: Feb 5, 2026, 07:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ABG. ABG was compared to 29 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of ABG get a neutral evaluation. Nothing too spectacular is happening here. ABG is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year ABG was profitable.
  • ABG had a positive operating cash flow in the past year.
  • ABG had positive earnings in each of the past 5 years.
  • In the past 5 years ABG always reported a positive cash flow from operatings.
ABG.DE Yearly Net Income VS EBIT VS OCF VS FCFABG.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.03%, ABG is in line with its industry, outperforming 41.38% of the companies in the same industry.
  • ABG's Return On Equity of 103.06% is amongst the best of the industry. ABG outperforms 100.00% of its industry peers.
  • ABG has a better Return On Invested Capital (14.50%) than 96.55% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ABG is significantly above the industry average of 6.49%.
Industry RankSector Rank
ROA 2.03%
ROE 103.06%
ROIC 14.5%
ROA(3y)2.36%
ROA(5y)2.55%
ROE(3y)223.66%
ROE(5y)N/A
ROIC(3y)15.04%
ROIC(5y)14.55%
ABG.DE Yearly ROA, ROE, ROICABG.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500

1.3 Margins

  • ABG's Profit Margin of 0.48% is on the low side compared to the rest of the industry. ABG is outperformed by 68.97% of its industry peers.
  • ABG's Profit Margin has declined in the last couple of years.
  • ABG's Operating Margin of 1.17% is on the low side compared to the rest of the industry. ABG is outperformed by 86.21% of its industry peers.
  • In the last couple of years the Operating Margin of ABG has grown nicely.
  • With a Gross Margin value of 3.51%, ABG is not doing good in the industry: 75.86% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of ABG has grown nicely.
Industry RankSector Rank
OM 1.17%
PM (TTM) 0.48%
GM 3.51%
OM growth 3Y-0.12%
OM growth 5Y1.81%
PM growth 3Y-12.1%
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y5.18%
ABG.DE Yearly Profit, Operating, Gross MarginsABG.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 -1 2 3

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ABG is still creating some value.
  • The number of shares outstanding for ABG has been reduced compared to 1 year ago.
  • The number of shares outstanding for ABG has been reduced compared to 5 years ago.
  • The debt/assets ratio for ABG is higher compared to a year ago.
ABG.DE Yearly Shares OutstandingABG.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
ABG.DE Yearly Total Debt VS Total AssetsABG.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 4.91 indicates that ABG is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of ABG (4.91) is better than 93.10% of its industry peers.
  • The Debt to FCF ratio of ABG is 2.39, which is a good value as it means it would take ABG, 2.39 years of fcf income to pay off all of its debts.
  • ABG has a Debt to FCF ratio of 2.39. This is amongst the best in the industry. ABG outperforms 93.10% of its industry peers.
  • ABG has a Debt/Equity ratio of 5.00. This is a high value indicating a heavy dependency on external financing.
  • ABG has a worse Debt to Equity ratio (5.00) than 82.76% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for ABG, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 5
Debt/FCF 2.39
Altman-Z 4.91
ROIC/WACC1.66
WACC8.72%
ABG.DE Yearly LT Debt VS Equity VS FCFABG.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 0.90 indicates that ABG may have some problems paying its short term obligations.
  • ABG has a Current ratio (0.90) which is in line with its industry peers.
  • ABG has a Quick Ratio of 0.90. This is a bad value and indicates that ABG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ABG's Quick ratio of 0.55 is on the low side compared to the rest of the industry. ABG is outperformed by 65.52% of its industry peers.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.55
ABG.DE Yearly Current Assets VS Current LiabilitesABG.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 16.21% over the past year.
  • ABG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.14% yearly.
  • Looking at the last year, ABG shows a quite strong growth in Revenue. The Revenue has grown by 9.31% in the last year.
  • Measured over the past years, ABG shows a quite strong growth in Revenue. The Revenue has been growing by 11.09% on average per year.
EPS 1Y (TTM)16.21%
EPS 3Y13.21%
EPS 5Y15.14%
EPS Q2Q%14.97%
Revenue 1Y (TTM)9.31%
Revenue growth 3Y10.43%
Revenue growth 5Y11.09%
Sales Q2Q%5.92%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.78% on average over the next years. This is quite good.
  • Based on estimates for the next years, ABG will show a small growth in Revenue. The Revenue will grow by 6.67% on average per year.
EPS Next Y11.34%
EPS Next 2Y11.04%
EPS Next 3Y10.89%
EPS Next 5Y10.78%
Revenue Next Year6.2%
Revenue Next 2Y6.39%
Revenue Next 3Y6.52%
Revenue Next 5Y6.67%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ABG.DE Yearly Revenue VS EstimatesABG.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100B 200B 300B 400B
ABG.DE Yearly EPS VS EstimatesABG.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20 25

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 20.94, the valuation of ABG can be described as rather expensive.
  • ABG's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of ABG to the average of the S&P500 Index (28.06), we can say ABG is valued slightly cheaper.
  • With a Price/Forward Earnings ratio of 18.81, ABG is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, ABG is valued a bit more expensive than 72.41% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.86, ABG is valued a bit cheaper.
Industry RankSector Rank
PE 20.94
Fwd PE 18.81
ABG.DE Price Earnings VS Forward Price EarningsABG.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ABG indicates a slightly more expensive valuation: ABG is more expensive than 75.86% of the companies listed in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as ABG.
Industry RankSector Rank
P/FCF 20.26
EV/EBITDA 14.18
ABG.DE Per share dataABG.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of ABG may justify a higher PE ratio.
PEG (NY)1.85
PEG (5Y)1.38
EPS Next 2Y11.04%
EPS Next 3Y10.89%

4

5. Dividend

5.1 Amount

  • ABG has a yearly dividend return of 0.68%, which is pretty low.
  • ABG's Dividend Yield is comparable with the industry average which is at 1.61.
  • Compared to an average S&P500 Dividend Yield of 1.80, ABG's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.68%

5.2 History

  • The dividend of ABG is nicely growing with an annual growth rate of 6.10%!
Dividend Growth(5Y)6.1%
Div Incr YearsN/A
Div Non Decr YearsN/A
ABG.DE Yearly Dividends per shareABG.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2025 2026 0.5 1 1.5

5.3 Sustainability

  • ABG pays out 28.12% of its income as dividend. This is a sustainable payout ratio.
  • ABG's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.12%
EPS Next 2Y11.04%
EPS Next 3Y10.89%
ABG.DE Yearly Income VS Free CF VS DividendABG.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B
ABG.DE Dividend Payout.ABG.DE Dividend Payout, showing the Payout Ratio.ABG.DE Dividend Payout.PayoutRetained Earnings

CENCORA INC

FRA:ABG (2/5/2026, 7:00:00 PM)

284

-0.85 (-0.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05
Earnings (Next)02-04
Inst Owners95.74%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap55.09B
Revenue(TTM)321.33B
Net Income(TTM)1.55B
Analysts80
Price Target332.07 (16.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.68%
Yearly Dividend1.89
Dividend Growth(5Y)6.1%
DP28.12%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.78%
Min EPS beat(2)0.41%
Max EPS beat(2)3.15%
EPS beat(4)4
Avg EPS beat(4)3.89%
Min EPS beat(4)0.41%
Max EPS beat(4)6.6%
EPS beat(8)8
Avg EPS beat(8)4.4%
EPS beat(12)12
Avg EPS beat(12)3.83%
EPS beat(16)15
Avg EPS beat(16)3.46%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)-0.35%
Revenue beat(4)1
Avg Revenue beat(4)0.16%
Min Revenue beat(4)-1.29%
Max Revenue beat(4)2.93%
Revenue beat(8)4
Avg Revenue beat(8)0.09%
Revenue beat(12)7
Avg Revenue beat(12)0.91%
Revenue beat(16)9
Avg Revenue beat(16)0.67%
PT rev (1m)-0.53%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.01%
EPS NY rev (1m)0.02%
EPS NY rev (3m)0.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.33%
Valuation
Industry RankSector Rank
PE 20.94
Fwd PE 18.81
P/S 0.2
P/FCF 20.26
P/OCF 16.77
P/B 43.09
P/tB N/A
EV/EBITDA 14.18
EPS(TTM)13.56
EY4.77%
EPS(NY)15.09
Fwd EY5.32%
FCF(TTM)14.02
FCFY4.94%
OCF(TTM)16.94
OCFY5.96%
SpS1404.48
BVpS6.59
TBVpS-69.68
PEG (NY)1.85
PEG (5Y)1.38
Graham Number44.84
Profitability
Industry RankSector Rank
ROA 2.03%
ROE 103.06%
ROCE 19.96%
ROIC 14.5%
ROICexc 18.88%
ROICexgc N/A
OM 1.17%
PM (TTM) 0.48%
GM 3.51%
FCFM 1%
ROA(3y)2.36%
ROA(5y)2.55%
ROE(3y)223.66%
ROE(5y)N/A
ROIC(3y)15.04%
ROIC(5y)14.55%
ROICexc(3y)19.39%
ROICexc(5y)18.79%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)20.71%
ROCE(5y)20.04%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-3.36%
ROICexc growth 5Y-5.64%
OM growth 3Y-0.12%
OM growth 5Y1.81%
PM growth 3Y-12.1%
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y5.18%
F-Score6
Asset Turnover4.2
Health
Industry RankSector Rank
Debt/Equity 5
Debt/FCF 2.39
Debt/EBITDA 1.57
Cap/Depr 62.52%
Cap/Sales 0.21%
Interest Coverage 10.51
Cash Conversion 80.48%
Profit Quality 206.36%
Current Ratio 0.9
Quick Ratio 0.55
Altman-Z 4.91
F-Score6
WACC8.72%
ROIC/WACC1.66
Cap/Depr(3y)50.93%
Cap/Depr(5y)61.57%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.19%
Profit Quality(3y)200.95%
Profit Quality(5y)175.46%
High Growth Momentum
Growth
EPS 1Y (TTM)16.21%
EPS 3Y13.21%
EPS 5Y15.14%
EPS Q2Q%14.97%
EPS Next Y11.34%
EPS Next 2Y11.04%
EPS Next 3Y10.89%
EPS Next 5Y10.78%
Revenue 1Y (TTM)9.31%
Revenue growth 3Y10.43%
Revenue growth 5Y11.09%
Sales Q2Q%5.92%
Revenue Next Year6.2%
Revenue Next 2Y6.39%
Revenue Next 3Y6.52%
Revenue Next 5Y6.67%
EBIT growth 1Y23.25%
EBIT growth 3Y10.3%
EBIT growth 5Y13.11%
EBIT Next Year23.6%
EBIT Next 3Y13.21%
EBIT Next 5YN/A
FCF growth 1Y6.99%
FCF growth 3Y13.28%
FCF growth 5Y11.79%
OCF growth 1Y11.2%
OCF growth 3Y12.76%
OCF growth 5Y11.92%

CENCORA INC / ABG.DE FAQ

What is the fundamental rating for ABG stock?

ChartMill assigns a fundamental rating of 5 / 10 to ABG.DE.


What is the valuation status for ABG stock?

ChartMill assigns a valuation rating of 2 / 10 to CENCORA INC (ABG.DE). This can be considered as Overvalued.


What is the profitability of ABG stock?

CENCORA INC (ABG.DE) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for ABG stock?

The Price/Earnings (PE) ratio for CENCORA INC (ABG.DE) is 20.94 and the Price/Book (PB) ratio is 43.09.


Is the dividend of CENCORA INC sustainable?

The dividend rating of CENCORA INC (ABG.DE) is 4 / 10 and the dividend payout ratio is 28.12%.